Digbi Health's Approach: Targeted Modulation of the Gut Microbiome to Support GLP Drugs Digbi Health has pioneered a Precision Biology-based personalized dietary and lifestyle intervention that leverages the gut microbiome's influence on metabolic regulators like GLP-1, GIP, DPP-4, and PYY
Cancer surveillance: 510 years of real-world data are needed to rule out rare cancer signals
M.FreyF
Side Effects The most common side effects of GLP-1 agonists include: Loss of appetite, Nausea, Vomiting, Diarrhea, and Constipation
For oral semaglutide, follow the strict fasting requirements (take 30 minutes before first food or other medications with no more than 4 ounces of water)
If you have medical conditions, take medications, or are trying to manage blood sugar or weight, talk to a clinician first